RITUXAN MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Rituxan Market, By Indication (Non-Hodgkin’s Lymphoma (NHL), Mature B-cell Non-Hodgkin’s Lymphoma, Mature B-cell Acute Leukemia, Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA), and Pemphigus Vulgaris (PV)), By Dosage Forms and Strength (100 mg/10 mL (single-use vial) and 500 mg/50 mL (single-use vial)), By Patient Age Group (Pediatric, Adult, and Geriatric), By End User (Hospitals, Oncology Centers, Infusion Centers, Ambulatory Surgical Centers, and Others (Specialty Clinics, etc.)), By Sales Channel (Online and Offline), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 11 Mar, 2026
Code: CMI8120
Page number: 165
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Rituxan Market, By Indication
  - Global Rituxan Market, By Dosage Forms and Strength
  - Global Rituxan Market, By Patient Age Group
  - Global Rituxan Market, By End User
  - Global Rituxan Market, By Sales Channel
  - Global Rituxan Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
- Reimbursement Scenario
- Epidemiology
- Pricing Analysis
Global Rituxan Market, By Indication, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Non-Hodgkin’s Lymphoma (NHL)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Mature B-cell Non-Hodgkin’s Lymphoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Mature B-cell Acute Leukemia
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Chronic Lymphocytic Leukemia (CLL)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Rheumatoid Arthritis (RA)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Pemphigus Vulgaris (PV)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Global Rituxan Market, By Dosage Forms and Strength, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- 100 mg/10 mL (single-use vial)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- 500 mg/50 mL (single-use vial)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Global Rituxan Market, By Patient Age Group, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Pediatric
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Adult
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Geriatric
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Global Rituxan Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Oncology Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Infusion Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Ambulatory Surgical Centers
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (Specialty Clinics, etc.)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Global Rituxan Market, By Sales Channel, 2021 - 2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Online
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Offline
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
Global Rituxan Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
  - Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Forms and Strength, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Forms and Strength, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Forms and Strength, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Forms and Strength, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Forms and Strength, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Forms and Strength, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Sales Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Genentech (Part of Roche)
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Biogen
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Chugai Pharmaceutical Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- ZENYAKU KOGYO CO., LTD
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on ‘Rituxan Market' - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now